DEUTSCHE BANK AG\ - SYNTHETIC BIOLOGICS INC ownership

SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U201. A total of 27 filers reported holding SYNTHETIC BIOLOGICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SYNTHETIC BIOLOGICS INC
ValueSharesWeighting
Q4 2019$2,0004,2680.00%
Other shareholders
SYNTHETIC BIOLOGICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Virtu Financial LLC 331,543$90,0000.01%
Sterneck Capital Management, LLC 25,000$7,0000.00%
Landmark Financial Advisors, LLC 24,200$7,0000.00%
Jacobi Capital Management LLC 18,500$5,0000.00%
MSD Partners, L.P. 349,290$96,0000.00%
Focused Wealth Management, Inc 500$00.00%
UBS Group AG 97,378$26,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,300$20,0000.00%
IFP Advisors, Inc 13,825$5,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1$00.00%
View complete list of SYNTHETIC BIOLOGICS INC shareholders